Obesimed Forte 42 c

Nom de l'organisation

PK Benelux BV

SRN

NL-MF-000006672

Statut du fabricant

Actif

1 avertissement enregistré — faire défiler le panneau pour tout voir.

• CW999

  Warnings: • Do not use Obesimed® Forte in the following situations: - If you are allergic to one or more of the ingredients; - If you have suffered from gastrointestinal disorders; - If you have suffered from esophageal stenosis or pre-existing bowel abnormalities; - When pregnant or breastfeeding. • If you have any doubts about whether you can use Obesimed® Forte and/or can use it in combination with medication, consult your doctor or pharmacist first. • Do not open the capsule before using. • Keep out of reach of small children. Possible side effects: Obesimed® Forte is well tolerated but can lead to a few side effects although not everybody suffers from these side effects. Mild stomach and intestinal complaints may be experienced initially such as thin or loose stools, mild diarrhea, reflux and gas formation or constipation. Usually these side effects disappear after a few days. To avoid these side effects start with a low dosage (1 capsule per meal) and then gradually increase the intake as the body adjusts. If any of these side effects becomes serious, or if you notice any side effects not listed in this instructions for use, consult your doctor or pharmacist. Use during pregnancy and/or breastfeeding: Losing weight is not allowed when pregnant or breastfeeding

Marché principal en Portugal ; disponible dans 1 pays au total.

Dénomination commerciale

Obesimed Forte 42 c

Code d'UDI-DI

D-018508N3

Basic UDI-DI

B-018508N3

Numéro de référence/catalogue

018508

Entité d'attribution

EUDAMED

Catégorie de risque

Classe IIa

Législation applicable

MDD [Directive 93/42/CEE relative aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

To treat obesity and overweight in adults

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel

D-018508N3

La génération de DataMatrix prend en charge les IUD émis par GS1. La prise en charge HIBCC / ICCBBA arrive bientôt.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• G0402ORALLY ADMINISTERED DEVICES FOR APPETITE CONTROL AND REDUCTION OF INTESTINAL ABSORPTION